BG
STIM icon

Bellevue Group’s Neuronetics STIM Stock Holding History

Bellevue Group’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-250,000
Closed -$483K – 222
2020
Q2 		$483K Sell
250,000
-75,961
-23% -$156K 0.01% 166
2020
Q1 		$616K Hold
325,961
– – 0.01% 151
2019
Q4 		$1.46M Hold
325,961
– – 0.02% 143
2019
Q3 		$2.71M Buy
325,961
+1,182
+0.4% +$12.9K 0.05% 124
2019
Q2 		$4.06M Buy
324,779
+29,442
+10% +$416K 0.07% 109
2019
Q1 		$4.5M Buy
295,337
+129,937
+79% +$2.15M 0.25% 79
2018
Q4 		$3.2M Buy
165,400
+53,493
+48% +$1.17M 0.21% 87
2018
Q3 		$3.59M Buy
111,907
+61,907
+124% +$1.88M 0.23% 87
2018
Q2 		$1.32M Buy
+50,000
New +$1.36M 0.11% 109

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group's STIM Position: Q3 2020 in Review

Bellevue Group sold out of Neuronetics (STIM) in Q3 2020, closing a stake of 250,000 shares — an estimated $483K sold.

Bellevue Group first reported a position in STIM in Q2 2018 and held it in 9 quarters. The position peaked at $4.5M in Q1 2019. 55 funds tracked by Wall St. Rank hold STIM as of Q3 2020.

  • Bellevue Group reported no remaining Neuronetics position as of Q3 2020 after selling out during the quarter.
  • Bellevue Group sold 250,000 Neuronetics shares in Q3 2020, an estimated $483K.
  • Bellevue Group first reported a position in Neuronetics in Q2 2018 and held it in 9 quarters.
  • Bellevue Group's Neuronetics position peaked at $4.5M in Q1 2019.
  • 55 funds tracked by Wall St. Rank held Neuronetics as of Q3 2020.

Based on Bellevue Group's 13F filing for Q3 2020, filed 16 Nov 2020.